13th Annual Chicago Diabetes Day Conference

13th Annual Chicago Diabetes Day Conference is organized by The University of Chicago - Center for Continuing Medical Education and will be held on May 12, 2018 at Biological Science Learning Center, Chicago, Illinois, United States of America.

The target audience for this medical event is physicians, scientists, nurse practitioners, nurses, diabetes educators, students, and other healthcare professionals interested in the scientific advances in diabetes diagnosis and treatment. This CME Conference has been approved for a maximum of 2.25 AMA PRA Category 1 Credits.

Conference Description:
This conference is intended to serve as a forum for basic and clinical investigators, clinicians, and pharmaceutical industry personnels in Chicago and the Midwest to meet, share information, and discuss common interests with the goal of fostering collaborations between individuals and between institutions. Ample opportunities will exist throughout the day to meet with your colleagues. A poster session is planned for those who wish to share findings from current basic, clinical, or translational research. The top eight posters will receive an award of $100 each. We are excited about this event and encourage you to attend what promises to be a stimulating and productive day.

Conference Objectives:
At the conclusion of this activity, participants will be able to:
• Identify the function and structure of the beta cell from a scientific and clinical perspective;
• Explain how to augment treatment for patients who have not achieved glycemic control;
• Summarize the cultural differences and unique characteristics of diabetes in various patient populations throughout the world;
• Describe how to develop evidence-based, patient-specific glycemic and non-glycemic treatment goals for patients with type 2 diabetes mellitus focusing on cardiovascular risk reduction;
• Discuss treatment regimens and patient management techniques that can be affective at achieving and maintaining high adherence to therapy;
• Assess how to support patients who have diabetes while considering the psychosocial barriers to treatment.

Additional details will be posted as soon as they are available.